Climb Bio, Inc. (CLYM)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for Climb Bio, Inc.. Most notable: 2026-07-01: Filed 8-K disclosing director or officer change; 2026-09-15: Thomas Stephen Basil (director) sold $1.4M of stock. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Large insider saleThomas Stephen Basil (director) sold $1.4M of stock
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Insider purchaseKolchinsky Peter (director) bought $290k of stock
- Insider purchaseRA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; RA Capital Nexus Fund II, L.P.; RA Capital Nexus Fund III, L.P.; Kolchinsky Peter; Shah Rajeev M. (director) bought $290k of stock
- Insider purchaseKolchinsky Peter (director) bought $465k of stock
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-15 | Thomas Stephen Basil | director | S | 100,000 | 13.67 | $1,366,820 |
| 2026-06-29 | Brennan Aoife | director | S | 30,902 | 13.17 | $406,979 |
| 2026-06-29 | Brennan Aoife | director | S | 30,902 | 13.17 | $406,979 |
| 2026-06-27 | Brennan Aoife | director | M | 68,750 | — | — |
| 2026-06-27 | Brennan Aoife | director | M | 68,750 | — | — |
| 2026-02-26 | Thomas Stephen Basil | director | S | 16,313 | 7.01 | $114,354 |
| 2026-02-26 | Thomas Stephen Basil | director | S | 16,313 | 7.01 | $114,289 |
| 2026-02-25 | Thomas Stephen Basil | director | S | 33,687 | 7 | $235,809 |
| 2026-02-25 | Thomas Stephen Basil | director | S | 33,687 | 7 | $235,964 |
| 2026-02-13 | Thomas Stephen Basil | director | S | 10,000 | 5.81 | $58,100 |
| 2026-02-13 | Thomas Stephen Basil | director | S | 10,000 | 5.81 | $58,141 |
| 2026-02-12 | Thomas Stephen Basil | director | S | 90,000 | 5.23 | $470,700 |
| 2026-02-12 | Thomas Stephen Basil | director | S | 90,000 | 5.23 | $470,988 |
| 2026-01-05 | RA Capital Healthcare Fund LP | director | P | 7,111 | 3.5 | $24,889 |
| 2026-01-05 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; RA Capital Nexus Fund II, L.P.; RA Capital Nexus Fund III, L.P.; Kolchinsky Peter; Shah Rajeev M. | director | P | 7,111 | 3.5 | $24,889 |
| 2025-12-12 | Kolchinsky Peter | director | P | 101,462 | 2.86 | $290,181 |
| 2025-12-12 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; RA Capital Nexus Fund II, L.P.; RA Capital Nexus Fund III, L.P.; Kolchinsky Peter; Shah Rajeev M. | director | P | 101,462 | 2.86 | $290,181 |
| 2025-12-11 | Kolchinsky Peter | director | P | 213,099 | 2.18 | $464,556 |
| 2025-12-11 | Kolchinsky Peter | director | D | 20,440,000 | 0 | $0 |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; RA Capital Nexus Fund II, L.P.; RA Capital Nexus Fund III, L.P.; Kolchinsky Peter; Shah Rajeev M. | director | D | 20,440,000 | 0 | $0 |
| 2025-12-11 | RA CAPITAL MANAGEMENT, L.P.; RA Capital Healthcare Fund LP; RA Capital Nexus Fund, L.P.; RA Capital Nexus Fund II, L.P.; RA Capital Nexus Fund III, L.P.; Kolchinsky Peter; Shah Rajeev M. | director | P | 213,099 | 2.18 | $464,556 |
| 2025-08-07 | Thomas Stephen Basil | director | A | 100,375 | 0 | $0 |
| 2025-08-07 | Thomas Stephen Basil | director | A | 100,375 | 0 | $0 |
| 2025-06-30 | Brennan Aoife | director | S | 20,618 | 1.22 | $25,154 |
| 2025-06-30 | Brennan Aoife | director | S | 20,618 | 1.22 | $25,154 |
| 2025-06-27 | Brennan Aoife | director | M | 68,750 | — | — |
| 2025-06-27 | Thomas Stephen Basil | director | M | 25,094 | — | — |
| 2025-06-27 | Brennan Aoife | director | M | 68,750 | — | — |
| 2025-06-27 | Thomas Stephen Basil | director | M | 25,094 | — | — |
| 2025-06-20 | Pimblett Emily | officer | S | 1,242 | 1.24 | $1,540 |
| 2025-06-20 | Pimblett Emily | officer | S | 1,242 | 1.24 | $1,540 |
| 2025-06-18 | Pimblett Emily | officer | M | 5,000 | — | — |
| 2025-06-18 | Pimblett Emily | officer | M | 5,000 | — | — |
| 2025-03-27 | Thomas Stephen Basil | director | M | 25,093 | — | — |
| 2025-03-27 | Thomas Stephen Basil | director | M | 25,093 | — | — |
| 2025-03-20 | Pimblett Emily | officer | S | 1,199 | 1.31 | $1,571 |
| 2025-03-20 | Pimblett Emily | officer | S | 1,199 | 1.31 | $1,571 |
| 2025-03-18 | Pimblett Emily | officer | M | 5,000 | — | — |
| 2025-03-18 | Pimblett Emily | officer | M | 5,000 | — | — |
| 2025-01-01 | Thomas Stephen Basil | director | M | 50,188 | — | — |
| 2025-01-01 | Thomas Stephen Basil | director | M | 50,188 | — | — |
| 2024-12-19 | Pimblett Emily | officer | S | 1,235 | 2.02 | $2,495 |
| 2024-12-19 | Pimblett Emily | officer | S | 1,235 | 2.02 | $2,495 |
| 2024-12-18 | Pimblett Emily | officer | M | 5,000 | — | — |
| 2024-12-18 | Pimblett Emily | officer | M | 5,000 | — | — |
| 2024-09-20 | Pimblett Emily | officer | S | 9 | 8.06 | $73 |
| 2024-09-20 | Pimblett Emily | officer | S | 1,182 | 8.18 | $9,669 |
| 2024-09-20 | Pimblett Emily | officer | S | 1,182 | 8.18 | $9,669 |
| 2024-09-20 | Pimblett Emily | officer | S | 9 | 8.06 | $73 |
| 2024-09-18 | Pimblett Emily | officer | M | 5,000 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-17 4
- 2026-09-15 144
- 2026-09-03 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-14 8-K
- 2026-08-06 10-Q
- 2026-08-06 8-K
- 2026-07-08 SCHEDULE 13G
- 2026-07-07 SCHEDULE 13D/A
- 2026-07-01 4
- 2026-07-01 4
- 2026-07-01 3
- 2026-07-01 8-K
- 2026-06-30 4
- 2026-06-30 144
- 2026-06-12 8-K
- 2026-06-12 424B5
- 2026-06-11 8-K
- 2026-06-09 EFFECT
- 2026-06-09 424B3